2025-04-13 15:31:34
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
SRF Ltd Q4FY21 consolidated PAT rises to Rs. 380.92 crore
Posted On : 2021-05-05 14:29:46( TIMEZONE : IST )
SRF LTD. has reported financial results for the period ended March 31, 2021.
Financial Results (Q4 FY20-21) - QoQ Comparison
The company has reported total income of Rs.2620.61 crores during the period ended March 31, 2021 as compared to Rs.2168.09 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.380.92 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.324.73 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.64.30 for the period ended March 31, 2021 as compared to Rs.55.09 for the period ended December 31, 2020.
| Financials | Q4 FY20-21 | Q3 FY20-21 | % Change |
| Total Income | ₹ 2620.61 crs | ₹ 2168.09 crs |  20.87% |
| Net Profit | ₹ 380.92 crs | ₹ 324.73 crs | 17.3% |
| EPS | ₹ 64.30 | ₹ 55.09 | 16.72% |
Financial Results (Q4 FY20-21) - YoY Comparison
The company has reported total income of Rs.2620.61 crores during the period ended March 31, 2021 as compared to Rs.1864.15 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.380.92 crores for the period ended March 31, 2021 as against net profit / (loss) of Rs.185.75 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.64.30 for the period ended March 31, 2021 as compared to Rs.32.32 for the period ended March 31, 2020.
| Financials | Q4 FY20-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 2620.61 crs | ₹ 1864.15 crs | 40.58% |
| Net Profit | ₹ 380.92 crs | ₹ 185.75 crs | 105.07% |
| EPS | ₹ 64.30 | ₹ 32.32 | 98.95% |
Financial Results (Year ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.8454.53 crores during the 12 months period ended March 31, 2021 as compared to Rs.7258.46 crores during the 12 months period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.1197.94 crores for the 12 months period ended March 31, 2021 as against net profit / (loss) of Rs.1019.09 crores for the 12 months period ended March 31, 2020.
The company has reported EPS of Rs.205.54 for the 12 months period ended March 31, 2021 as compared to Rs.177.29 for the 12 months period ended March 31, 2020.
| Financials | Year Ended FY20-21 | Year Ended FY19-20 | % Change |
| Total Income | ₹ 8454.53 crs | ₹ 7258.46 crs | 16.48% |
| Net Profit | ₹ 1197.94 crs | ₹ 1019.09 crs | 17.55% |
| EPS | ₹ 205.54 | ₹177.29 | 15.93% |
Commenting on the results, Managing Director, Ashish Bharat Ram said, "The company has had an excellent quarter all around, with the Specialty Chemicals and the Packaging Films Businesses performing exceedingly well. While I remain reasonably optimistic of the year ahead, we are seeing some disruptions at our workplace emanating from the second wave of the COVID-19 outbreak. Looking after our communities and employees is of paramount importance to us at the moment."
Consolidated Q4FY21 Segment Results
The Chemicals Business reported an increase of 31% in its segment revenue from ₹882 crore to ₹1,153 crore during Q4FY21 over CPLY. The operating profit of the Chemicals Business increased 73% from ₹159 crore to ₹275 crore in Q4FY21 over CPLY. During the quarter, the Specialty Chemicals Business performed exceptionally well owing to a strong demand from the overseas markets and enhanced volumes of certain key products supplied to our major customers in Europe. The Fluorochemicals Business witnessed higher sales volumes in the refrigerants segment from both domestic and export market. In addition, healthy contribution from the chloromethanes segment augmented the overall results. However, the Fluorochemicals Business is witnessing an impact of the micro lockdowns and certain restrictions imposed by the local authorities as a part of COVID-19 response measures which, though currently not significant, may have an adverse impact on business performance in the short term.
The Packaging Films Business reported an increase of 63% in its segment revenue from ₹601 crore to ₹980 crore during Q4FY21 when compared with CPLY. The operating profit of the Packaging Films Business increased 67% from ₹131 crore to ₹219 crore in Q4FY21 over CPLY. Volume growth, better cost efficiencies, and higher customer-centricity have resulted in the Business establishing itself as a global major in the Packaging Films industry. Additionally, new capacities in Hungary and Thailand and enhanced sales of Value-Added Products (VAPs) have contributed significantly to the overall performance.
The Technical Textiles Business reported an increase of 26% in its segment revenue from ₹317 crore to ₹401 crore during Q4FY21 over CPLY. The operating profit of the Technical Textiles Business increased 96% from ₹37 crore to ₹73 crore in Q4FY21 over CPLY. Fast recovery in the tyre industry and a healthy contribution from the Belting Fabrics segment augured well for the Technical Textiles Business.
The Other Businesses reported an increase of 35% in its segment revenue from ₹58 crore to ₹78 crore in Q4FY21 when compared with CPLY. The operating profit of the Other Businesses increased 66% from ₹5 crore to ₹9 crore in Q4FY21 over CPLY. Both the Coated and Laminated Fabrics Business performed very well in a difficult external environment.
Shares of SRF LTD. was last trading in BSE at Rs.6710.4 as compared to the previous close of Rs. 6529.3. The total number of shares traded during the day was 19370 in over 2796 trades.
The stock hit an intraday high of Rs. 6809.6 and intraday low of 6521.95. The net turnover during the day was Rs. 129686862.
